A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a

Justyna Kozlowska1, Damian W Rivett1, Louic S Vermeer1

  • 1Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.

Insights

Metabolite profiles of Pseudomonas aeruginosa isolates from cystic fibrosis patients varied significantly. These differences correlated with patient lung function, suggesting potential for predicting disease progression and understanding microbial interactions in the airways.

Area of Science:

  • Microbiology
  • Metabolomics
  • Pulmonary Medicine

Background:

  • Chronic lung infections in cystic fibrosis (CF) are often dominated by Pseudomonas aeruginosa.
  • Understanding P. aeruginosa's impact on airway secretions is crucial for deciphering its in vivo behavior and interactions with other microbes.

Purpose of the Study:

  • To investigate if distinct phenotypes of clinical P. aeruginosa isolates correlate with differences in their spent culture media metabolite composition.
  • To explore the relationship between P. aeruginosa isolate characteristics, patient lung function (FEV1), and the airway environment.

Main Methods:

  • Utilized 1H NMR spectroscopy to analyze the metabolite profiles of spent culture media from 15 P. aeruginosa clinical isolates grown in an in vitro CF lower airway model.
  • Clustered isolates based on their metabolomic profiles.

Main Results:

  • Identified four distinct metabolomic clusters among the P. aeruginosa isolates.
  • Found significant correlations between isolate cluster membership and patient FEV1, as well as spent culture pH.
  • Observed significant divergence in metabolite production and consumption between different CF clinical isolates.

Conclusions:

  • P. aeruginosa isolate metabolomic profiles reflect distinct growth behaviors that correlate with patient lung function (FEV1).
  • Characterizing P. aeruginosa growth may aid in predicting lung function in CF patients.
  • Divergent metabolite profiles suggest dominant isolates can influence airway microbiota composition and P. aeruginosa behavior in vivo.